	Thoracic residual germ cell tumor resection after high-dose chemotherapy with autologous stem cell transplantation in relapsed patients. World J Urol Sponholz S, Karaindros G, Ntelli KC, Schirren M, Albers P, Che Y, Lorch A, Walles T, Fisseler-Eckhoff A, Schirren J. PMID: 41405695 [PubMed - indexed for MEDLINE]
	A commentary on "Abbreviated biparametric versus multiparametric MRI for the detection of clinically significant prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis". Int J Surg Tang W, Wang Y, Zhang Y. PMID: 41405335 [PubMed - as supplied by publisher]
	Clinical trial landscape of cellular therapies in bladder cancer. Int J Surg Zhang Y, Lv S, Li Z, Wang X, Zhu Y. PMID: 41405333 [PubMed - as supplied by publisher]
	Evaluating Molecular and Immune Biomarkers in Predicting Bladder Cancer Recurrence and Survival: A Systematic Review. Cureus Masood S, Shaikh A, Brar Y. PMID: 41404236 [PubMed]
	Renal Medullary Carcinoma: A Call for Screening and Early Diagnosis. Cureus Ponnam HC, Shirsat P, Parsi S, Ravi U, Sonavane K, Ravakhah K. PMID: 41404216 [PubMed]
	The S100 protein family in bladder cancer: mechanisms, clinical value, and targeted therapeutic prospects. Front Oncol Zhang L, Yang G, Huang L, Deng A, Ao M, Li J. PMID: 41404073 [PubMed]
	Case Report: High-volume, aggressive prostate cancer with borderline psa levels diagnosed by PSMA PET/CT-based comprehensive radiographic scheme and cognitive fusion targeted biopsy. Front Oncol Zhou Y, Qiu R, Dou M, Bi W, Yu Y. PMID: 41404062 [PubMed]
	Clinicohistopathological characteristics of renal cell carcinoma in Jordan. Future Sci OA Al-Zubi M, Haddad R, Badr A, Al Bibi H, Azzam S, Araydah M, Al Sharie A, Khattab K, Qasim H, Al Sharie S. PMID: 41403303 [PubMed]
	LAC-TME classifier: machine learning-driven model predicts survival and prioritizes targeted therapy in clear cell renal cell carcinoma. J Cancer Res Clin Oncol He J, Qi L, Cai Y, Chen M, Wang Y. PMID: 41402653 [PubMed - indexed for MEDLINE]
	Head-to-head comparison of (18)F-FAP-2286 PET/CT and (18)F-FDG PET/CT in the diagnosis and staging of clear cell renal cell carcinoma: a prospective study. Eur J Nucl Med Mol Imaging Cui Y, Wang S, Liu Y, Li X, Li Y, Li X. PMID: 41402648 [PubMed - as supplied by publisher]
	[Poly (ADP-ribose) polymerase inhibitor combination therapy in metastatic castration-resistant prostate cancer]. Urologie Ohlmann C, Gratzke C, Krabbe LM. PMID: 41402631 [PubMed - as supplied by publisher]
	Unravelling TPX2-centered co-expression networks as key drivers of aggressive prostate cancer. Sci Rep Sheibani-Tezerji R, Perez Malla CU, Wasinger G, Misura K, Haase A, Malzer A, Kalla J, Tran L, Egger G. PMID: 41402347 [PubMed - indexed for MEDLINE]
	Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette-Guérin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle-invasive bladder cancer (NMIBC). Ann Oncol. In press. https://doi.org/10.1016/j.annonc.2025.09.017. Eur Urol Oncol D'Andrea D, Shariat SF. PMID: 41402160 [PubMed - as supplied by publisher]
	Epigenetic Approaches to Prostate Cancer: Present Landscape and Future Prospects. Crit Rev Oncol Hematol Mesiakaris K, Kontogianni E, Logotheti S, Tzelepi V. PMID: 41401850 [PubMed - as supplied by publisher]
	Phase II trial protocol of focal prostate ablation combined with androgen deprivation therapy for prostate cancer treatment. PLoS One Koehler J, Lama D, Mendez M, Hsu WW, Oto A, Szmulewitz R, Sidana A. PMID: 41401176 [PubMed - indexed for MEDLINE]
	Prostate cancer treatment with electrochemotherapy (ECT): safety, efficacy and clinical experience in 144 patients. Radiol Oncol Stevanovic M, Heringer M, Hjouj M, Zanasi A, Terlizzi F, Stehling MK. PMID: 41401060 [PubMed - indexed for MEDLINE]
	Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab. Radiol Oncol Ozkan E, Koksal M, Ece B, Koyun M, Kuzu OF, Acikgoz Y, Algin E. PMID: 41401058 [PubMed - indexed for MEDLINE]
	An AI-engineered peptidyl fluorescence probe for GRP78: advancing renal cell carcinoma diagnosis. Chem Commun (Camb) Zhang L, An K, Yang Z, Yang M, Guo H, Jia Y, Liu K, Liang X, Hu C. PMID: 41400501 [PubMed - as supplied by publisher]
	Risk of malignancy of cytologic categories and post-biopsy clinical management of renal oncocytic neoplasms. Cancer Cytopathol Lin X. PMID: 41400420 [PubMed - indexed for MEDLINE]
	Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology Tjota MY, Kwon JW, Wanjari P, Antic T. PMID: 41400361 [PubMed - as supplied by publisher]

Articles 1 - 20 / 174620

Page 1 of 8731



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy